RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4635
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0835600; Gene model (P.falciparum): PF3D7_0934800; Gene product: cAMP-dependent protein kinase catalytic subunit (PKAc)
Details mutation: The mutant contains a FRTed ORF of the PKAc locus
Details conditional mutagenesis: The ORF of PKAc is removed in the sporozoite stage by the Flp/FRT system
Transgene
Transgene not Plasmodium: FlpL recombinase of yeast (FlpL)
Promoter: Gene model: PBANKA_1349800; Gene model (P.falciparum): PF3D7_1335900; Gene product: thrombospondin-related anonymous protein | sporozoite surface protein 2 (TRAP; SSP2; SSP-2)
3'UTR: Gene model: PBANKA_1349800; Gene product: sporozoite surface protein 2 thrombospondin-related anonymous protein (sporozoite surface protein 2; SSP2; SSP-2)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Liver stage;
Last modified: 10 June 2019, 12:42
  *RMgm-4635
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 31142638
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei TRAP/FlpL
Other information parent lineThis line expresses FlpL recombinase under the control of the TRAP promoter, active in the mosquito oocyst stage, and selectively excises the DNA sequence flanked by FRT sites (S. Mishra, K.A. Kumar and P. Sinnis, unpublished data). The FlpL expression cassette is introduced into the silent p230p gene locus (by GIMO transfection using line 1596cl1; RMgm-687) resulting in line 1809 (RMgm-4186). The line has been generated in Leiden and cloned in the Sinnis lab. This line does not contain a drug-selectable marker.
The mutant parasite was generated by
Name PI/ResearcherChoudhary HH, Mishra S
Name Group/DepartmentDivision of Parasitology
Name InstituteCSIR-Central Drug Research Institute
CityLucknow
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-4635
Principal namePKAc cKO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stagePKAc cKO sporozoites exhibit normal exocytosis and gliding motility and efficiently invade hepatocytes.
PKAc cKO parasites develop and egress normally in the liver.
PKAc is essential for hepatic merozoite infectivity. Mice inoculated with different doses of TRAP/FlpL merosomes became positive for blood stage parasites, whereas PKAc cKOmerosomes failed to initiate blood stage infection. Although mice inoculated with high doses of PKAc cKO merosomes became positive, they were carrying intact PKAc locus as revealed by genotyping.
These results demonstrate that PKAc is not important for any stage of preerythrocytic stages, but is essential for erythrocytic stages.
Additional remarks phenotype

Mutant/mutation
The mutant is a 'Flp/FRT conditional knock-out mutant' of PKAc. The mutant expresses the yeast FlpL recombinase under the control of the trap promoter  and contains a FRTed (part of the) ORF (open reading frame) of the PKAc locus. 

This mutant has been generated by replacement of the endogenous PKAc gene by an PKAc gene with a FRTed ORF in mutant RMgm-4186 that expresses FlpL. This mutant expresses the yeast FlpL recombinase under the control of the promoter of trap and does not contain a selectable marker. The flpl gene is integrated into the silent 230p locus by double cross-over integration.

(Part of)The PKAc ORF is removed from the genome by using the Flp/FRT site-specific recombination (SSR) system (see RMgm-269, RMgm-747). Removal of (part of) the FRTed ORF of PKAc  has been achieved by  transmission of the mutant through mosquitoes, thereby activating expression of the FlpL recombinase in sporozoites that resulted in the excision of the ORF of PKAc which was flanked by FRT sequences.

Protein (function)
cAMP/PKA signaling, known to be a major player in responding to host factors, is stimulated when parasite G-protein-coupled receptors receive extracellular signals and activate adenyl cyclases to produce cAMP. In Plasmodium merozoites, cAMP/PKA signaling plays an essential role in the invasion of erythrocytes by regulating cytosolic Ca++ levels and micronemal protein secretions. Similarly, the PKAc homolog in Toxoplasma gondii (PKAc1) plays a role in invasion via regulation of intracellular calcium. The cAMP-dependent PKA is a key mediator of the signal transduction pathway and plays diverse roles in the cell. The cAMP is generated by adenylyl cyclase, which primarily activates PKA. PKA is known to regulate different processes in eukaryotic cells. In a related apicomplexan parasite T. gondii, PKA has been shown to be involved in tachyzoite to bradyzoite development. PKA phosphorylates apical membrane antigen 1 (AMA1) protein of Plasmodium, and this phosphorylation event is essential for the invasion of new erythrocytes by merozoites. Unsuccesful attempts to disrupt the Plasmodium PKAc gene indicates an essential role in asexual blood stage development/multiplication.

Phenotype
PKAc cKO sporozoites exhibit normal exocytosis and gliding motility and efficiently invade hepatocytes. PKAc cKO parasites develop and egress normally in the liver.
PKAc is essential for hepatic merozoite infectivity. Mice inoculated with different doses of TRAP/FlpL merosomes became positive for blood stage parasites, whereas PKAc cKOmerosomes failed to initiate blood stage infection. Although mice inoculated with high doses of PKAc cKO merosomes became positive, they were carrying intact PKAc locus as revealed by genotyping.
These results demonstrate that PKAc is not important for any stage of preerythrocytic stages, but is essential for erythrocytic stages.

Additional information

Other mutants

 


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0835600
Gene Model P. falciparum ortholog PF3D7_0934800
Gene productcAMP-dependent protein kinase catalytic subunit
Gene product: Alternative namePKAc
Details of the genetic modification
Short description of the mutationThe mutant contains a FRTed ORF of the PKAc locus
Inducable system usedFlp/FRT
Short description of the conditional mutagenesisThe ORF of PKAc is removed in the sporozoite stage by the Flp/FRT system
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor conditional silencing of PKAc, its intron was flirted. For this, three fragments F1, F2, and F3 having a size of (1.2 kb), (1.6 kb), and (0.53 kb) were amplified using primer pairs 1066/1067, 1068/1069, and 1070/1071, respectively. F2 was directly ligated at the EcoRV site in the p3'TRAP-hDHFR-flirted vector. The fragment F2 reverse primer (1069) also contained 12 bp of TRAP 3'UTR for the continuation of UTR function as described previously. After confirmation of correct cloning of F2, fragments F1 and F3 were cloned sequentially at SacII/NotI and PstI/KpnI sites, respectively. The integration fragment was separated from the vector backbone by digesting with SacII/KpnI and transfected into the TRAP/FlpL line; S Mishra, KA Kumar, and P Sinnis,
unpublished data; RMgm-4186).
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameFlpL recombinase of yeast (FlpL)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe FlpL coding sequence was flanked by 1.58 kb and 0.55 kb of 5′ and 3′ regulatory sequences of trap, respectively.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1349800
Gene Model P. falciparum ortholog PF3D7_1335900
Gene productthrombospondin-related anonymous protein | sporozoite surface protein 2
Gene product: Alternative nameTRAP; SSP2; SSP-2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1349800
Gene productsporozoite surface protein 2 thrombospondin-related anonymous protein
Gene product: Alternative namesporozoite surface protein 2; SSP2; SSP-2
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4